Main Lecture
10.00-11.00 The bright (renal hemodynamics) and the dark (renal disease) face to Notch3.
Prof. Dr. Christos CHATZIANTONIOU, research director at INSERM (Paris, France).
Oral Communications
11.00-11.15 I. JADOT, V. COLOMBARO, B. MARTIN, I. HABSCH, O. BOTTON,
J. NORTIER, A-E. DECLÈVES, N. CARON (UNamur, ULBruxelles, UMons)
L-Arginine supplementation reduces fibrosis in a mouse model of chronic aristolochic acid induced nephropathy.
11.15-11.30 A. GEVAERT, H. SHAKERI, A. LELOUP, C.E. VAN HOVE, G.R.Y. DE MEYER, E.M. VAN CRAENENBROECK, C.J. VRINTS, K. LEMMENS (UAntwerpen)
Vascular senescence contributes to heart failure with preserved ejection fraction in senescence-accelerated mice fed a Western diet.
11.30-11.45
11.45-12.00
12.00-12.15
12.15-13.45
B. VAN DER VEKEN, G.R.Y. DE MEYER, W. MARTINET (UAntwerpen) Inhibition of VEGFreceptor signalling attenuates intraplaque angiogenesis and plaque destabilization in a mouse model of atherosclerotic plaque rupture.
E. VAN RYMENANT, K. BEERENS, C. BOYDENS, B. PAUWELS,
L. VANDEN DAELE, C. GROOTAERT, J. VAN CAMP, G. SMAGGHE,
A. KERIMI, G. WILLIAMSON, P. BROUCKAERT, J. VAN DE VOORDE (UGent, VIB, Univ. Leeds UK)
Ferulic acid-4-O-sulfate is a strong vasorelaxant of isolated mouse arteries acting through soluble guanylate cyclase and voltage-dependent potassium channels.
D. HOORELBEKE , M. DE BOCK, T. DELVAEYE, V. VAN HAVER,
H. THIERENS, D.V. KRYSKO , B. DESCAMPS , C. VANHOVE,
L. LEYBAERT, E. DECROCK (UGent, VIB)
The role of Connexin43 hemichannels, ATP release and the Ca2+/ROS/NO signaling axis in the radiation-induced bystander effect in brain micro- vascular endothelial cells.
Lunch – Guided Poster Session – General Assembly
Posters
(height 120 cm – width 100 cm)
-
B. MARTIN, C. WILKIN, I. JADOT, V. COLOMBARO, O. BOTTON, A-E. DECLÈVES, N. CARON (UNamur, UMons)
Involvement of adipokines in obesity-associated renal dysfunction. -
S. DOGNE, G. RATH, C. DESSY, B. CARON, B. FLAMION (UNamur, UCLouvain)
Hyaluronidase 1 deficiency preserves endothelial function and glycocalyx integrity in early streptozotocin-induced diabetes.
-
A. SANCHEZ, K. DEMYDENKO, C. JUNG, Y. A. ALPIZAR,
J. ALVAREZ-COLLAZO, J.L. ALVAREZ, P. HOET, M.A. VALVERDE, K. TALAVERA (KULeuven,Univ. Barcelona Spain, Univ. Havana Cuba) Silica nanoparticles inhibit the chemical activation of TRPV4.